Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bryan Phillips who wrote (190)	11/6/1997 1:24:00 AM
From: John Dwyer	Read Replies (1) of 1494

Hi Bryan, The trial period is eight weeks so I would expect the results early next year. The annual report also put it in that time frame. As for the stock price, if the news is good I would expect a big pop. I'll tell you the truth, though, NTII is a very weak company. According to their 10-K, they have been in violation of NASDAQ listing requirements since June and could be delisted. They have less than two quarters of cash left and their stock price is too low to offer more shares. They need additional financing or some kind of deal... soon. That news could have a profound affect on the stock price. OTOH, delisting would _also_ have a profound affect on the stock price... where's my Mylanta!! John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next